Bio-Rad Laboratories ROE 2010-2022 | BIO.B

Current and historical return on equity (ROE) values for Bio-Rad Laboratories (BIO.B) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Bio-Rad Laboratories ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2022-03-31 $-0.10B $10.18B -0.80%
2021-12-31 $4.25B $13.67B 33.16%
2021-09-30 $6.66B $15.33B 56.17%
2021-06-30 $4.05B $11.60B 39.55%
2021-03-31 $4.10B $10.61B 44.69%
2020-12-31 $3.81B $9.88B 47.06%
2020-09-30 $3.52B $8.83B 49.88%
2020-06-30 $1.95B $7.35B 31.73%
2020-03-31 $1.58B $6.29B 27.87%
2019-12-31 $1.76B $5.76B 33.11%
2019-09-30 $0.38B $5.13B 7.71%
2019-06-30 $0.90B $5.49B 18.76%
2019-03-31 $0.57B $4.86B 12.44%
2018-12-31 $0.37B $4.02B 8.09%
2018-09-30 $1.28B $4.90B 30.12%
2018-06-30 $1.03B $4.64B 27.64%
2018-03-31 $0.77B $4.49B 23.46%
2017-12-31 $0.12B $2.93B 4.32%
2017-09-30 $0.02B $2.85B 0.58%
2017-06-30 $0.01B $2.81B 0.44%
2017-03-31 $0.03B $2.71B 0.94%
2016-12-31 $0.03B $2.58B 0.96%
2016-09-30 $0.09B $2.70B 3.63%
2016-06-30 $0.09B $2.62B 3.69%
2016-03-31 $0.10B $2.54B 4.19%
2015-12-31 $0.11B $2.49B 4.60%
2015-09-30 $0.10B $2.43B 4.45%
2015-06-30 $0.10B $2.36B 4.35%
2015-03-31 $0.10B $2.20B 4.59%
2014-12-31 $0.09B $2.19B 4.07%
2014-09-30 $0.08B $2.18B 3.66%
2014-06-30 $0.06B $2.25B 2.82%
2014-03-31 $0.07B $2.23B 3.02%
2013-12-31 $0.08B $2.19B 3.71%
2013-09-30 $0.09B $2.12B 4.42%
2013-06-30 $0.14B $2.07B 7.00%
2013-03-31 $0.15B $2.03B 7.86%
2012-12-31 $0.17B $2.02B 8.64%
2012-09-30 $0.18B $1.94B 9.88%
2012-06-30 $0.19B $1.85B 10.38%
2012-03-31 $0.18B $1.84B 10.11%
2011-12-31 $0.18B $1.74B 10.57%
2011-09-30 $0.19B $1.69B 11.38%
2011-06-30 $0.19B $1.73B 11.79%
2011-03-31 $0.18B $1.61B 12.51%
2010-12-31 $0.19B $1.54B 13.35%
2010-09-30 $0.16B $1.43B 11.75%
2010-06-30 $0.15B $1.30B 11.74%
2010-03-31 $0.15B $1.30B 12.16%
2009-12-31 $0.15B $1.28B 12.36%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $14.907B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $163.597B 9.95
QIAGEN (QGEN) Netherlands $10.865B 17.15
Biohaven Pharmaceutical Holding (BHVN) United States $10.248B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.228B 0.00
Arcus Biosciences (RCUS) United States $1.901B 48.18
Emergent Biosolutions (EBS) United States $1.599B 6.85
Myovant Sciences (MYOV) United Kingdom $1.236B 0.00
Zymeworks (ZYME) Canada $0.320B 0.00
Gelesis Holdings (GLS) United States $0.114B 0.00
Enzo Biochem (ENZ) United States $0.104B 0.00
Ambrx Biopharma (AMAM) United States $0.103B 0.00
SQZ Biotechnologies (SQZ) United States $0.087B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00